Skip to content

Summit Therapeutics SMMT Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From AOCI Realized Upon Sale Or Liquidation Net Of Tax

Discontinued — last reported Q4 '25

Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From AOCI Realized Upon Sale Or Liquidation Net Of Tax at other companies

Autoliv logo
AutolivALV
$3M
Autoliv logo
AutolivALV
-$11M
ARE
Alexandria Real Estate EquitiesARE
$0
SS&C Technologies logo
SS&C TechnologiesSSNC
-$12.6M+39.7%
Acuity Brands logo
Acuity BrandsAYI
-$4.75M-439%
General Mills logo
General MillsGIS

Other financials

Income statement

See full
Revenue-
Operating income-$65.6M-81.2%
Net income-$189.4M-201%
EPS (diluted)-$0.24-167%

Balance sheet

See full
Cash & equivalents$8.2M+7.2%
Total debt$20.0M+211%
Total equity$545.9M+58.5%
Total assets$647.9M+68.8%

Cash flow

See full
Operating cash flow-$122.3M-99.9%
CapEx$245.0K-41.9%
Free cash flow-$122.5M-99.0%

Valuation

See full
Market cap$10.67B+3.3%
Enterprise value$10.68B+3.4%

Profitability

See full
Operating margin-268,266.8%-272,316pp
Net margin-271,685%-275,966pp
FCF margin-5,931.6%+4,730pp

Returns & leverage

See full
Return on equity-271%-1,725pp
Debt / equity0.0×
Current ratio7.4×-3.2×

Where this comes from

Reported directly by Summit Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax.

The official record: Summit Therapeutics’s 10-K, filed February 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Summit Therapeutics's other comprehensive income loss foreign currency transaction and translation reclassification adjustment from aoci realized upon sale or liquidation net of tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Summit Therapeutics's other comprehensive income loss foreign currency transaction and translation reclassification adjustment from AOCI realized upon sale or liquidation net of tax?
Summit Therapeutics (SMMT) reported other comprehensive income loss foreign currency transaction and translation reclassification adjustment from AOCI realized upon sale or liquidation net of tax of $0 in Q4 2025.
What does other comprehensive income loss foreign currency transaction and translation reclassification adjustment from AOCI realized upon sale or liquidation net of tax mean?
The realized currency gain or loss recognized when a foreign business unit is sold or liquidated.
How do you interpret other comprehensive income loss foreign currency transaction and translation reclassification adjustment from AOCI realized upon sale or liquidation net of tax?
An increase suggests a gain realized upon exiting a foreign market, while a decrease indicates a realized loss from such an exit.
How does other comprehensive income loss foreign currency transaction and translation reclassification adjustment from AOCI realized upon sale or liquidation net of tax compare across companies?
Relevant for companies undergoing restructuring or divestitures of international business segments.